Furthermore, as megakaryopoiesis is dysregulated in the contexts of aging [38] and myeloproliferative neoplasms such as essential thrombocytosis and myelofibrosis, understanding the extent to which alterations in PU.1 function contribute to these phenotypes remains an important area of investigation. This evidence concerns the gene SPI1 and myeloproliferative disorder.